Online citations, reference lists, and bibliographies.

The CBio Cancer Genomics Portal: An Open Platform For Exploring Multidimensional Cancer Genomics Data.

E. Cerami, J. Gao, U. Dogrusoz, Benjamin E. Gross, S. O. Sumer, B. A. Aksoy, A. Jacobsen, Caitlin Byrne, M. Heuer, E. Larsson, Yevgeniy Antipin, B. Reva, A. P. Goldberg, Chris Sander, N. Schultz
Published 2012 · Medicine, Biology
Cite This
Download PDF
Analyze on Scholarcy
Share
The cBio Cancer Genomics Portal (http://cbioportal.org) is an open-access resource for interactive exploration of multidimensional cancer genomics data sets, currently providing access to data from more than 5,000 tumor samples from 20 cancer studies. The cBio Cancer Genomics Portal significantly lowers the barriers between complex genomic data and cancer researchers who want rapid, intuitive, and high-quality access to molecular profiles and clinical attributes from large-scale cancer genomics projects and empowers researchers to translate these rich data sets into biologic insights and clinical applications.
This paper references
10.1038/nmeth0210-92
IntOGen: integration and data mining of multidimensional oncogenomic data
Gunes Gundem (2010)
The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data
E Cerami (2012)
Correction : The cBio Cancer Genomics Portal : An Open Platform for Exploring Multidimensional Cancer Genomics Data
E Cerami
10.1038/nature08987
International network of cancer genome projects
T. Hudson (2010)
10.1074/mcp.T500003-MCP200
Use of Reverse Phase Protein Microarrays and Reference Standard Development for Molecular Network Analysis of Metastatic Ovarian Carcinoma*
K. Sheehan (2005)
10.1038/nrc1457
Hallmarks of 'BRCAness' in sporadic cancers
Nicholas L. Turner (2004)
10.1038/nature07385
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
R. McLendon (2008)
10.1038/nbt.1754
Integrative Genomics Viewer
James T. Robinson (2011)
10.1038/nature10166
Integrated Genomic Analyses of Ovarian Carcinoma
D. Bell (2011)
10.1093/nar/gkq1039
Pathway Commons, a web resource for biological pathway data
Ethan G. Cerami (2011)
10.1093/nar/gkt1223
Pfam: the protein families database
R. Finn (2014)
10.1038/ng.619
Subtype-specific genomic alterations define new targets for soft tissue sarcoma therapy
J. Barretina (2010)
10.1093/annonc/mdm234
Founder mutations in BRCA1 and BRCA2 genes.
R. Ferla (2007)
International Network of Cancer Genome Projects
klaguia (2010)
10.1093/nar/gks1008
The UCSC Cancer Genomics Browser: update 2013
Mary J. Goldman (2013)
10.1093/nar/gkq1113
The UCSC cancer genomics browser: update 2011
J. Sanborn (2011)
10.1016/j.ccr.2010.05.026
Integrative genomic profiling of human prostate cancer.
B. Taylor (2010)
10.1093/database/bar026
International Cancer Genome Consortium Data Portal—a one-stop shop for cancer genomics data
Junjun Zhang (2011)
10.1093/nar/gkr407
Predicting the functional impact of protein mutations: application to cancer genomics
Boris A. Reva (2011)



This paper is referenced by
10.1200/JCO.2017.76.0033
Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer.
D. Stover (2018)
10.4149/neo_2016_408
Significant prognostic values of nuclear genes encoding mitochondrial complex I subunits in tumor patients.
L D Li (2016)
10.1128/JVI.00729-15
FUSE Binding Protein 1 Facilitates Persistent Hepatitis C Virus Replication in Hepatoma Cells by Regulating Tumor Suppressor p53
Updesh Dixit (2015)
10.3892/ol.2018.9855
Synchronous endometrioid endometrial and ovarian carcinomas are biologically related: A clinico-pathological and molecular (next generation sequencing) study of 22 cases
N. Hájková (2019)
10.1101/478735
B cells sustain inflammation and improve survival in human melanoma
Johannes Griss (2018)
10.4225/55/58D1BEF2E0A57
Characterization and functional analysis of mutant p53 secretome in human cancer
Reshma Shakya (2016)
10.1371/journal.pone.0050066
Phosphorylation of ΔNp63α via a Novel TGFβ/ALK5 Signaling Mechanism Mediates the Anti-Clonogenic Effects of TGFβ
Pratima Cherukuri (2012)
10.1016/j.celrep.2013.04.030
H/ACA small RNA dysfunctions in disease reveal key roles for noncoding RNA modifications in hematopoietic stem cell differentiation.
Cristian Bellodi (2013)
10.1158/2159-8290.CD-13-0103
Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers.
V. Lui (2013)
10.1186/1752-0509-7-S6-S9
Relative impact of multi-layered genomic data on gene expression phenotypes in serous ovarian tumors
Kyung-Ah Sohn (2013)
A computational approach to mitigate visualization design barriers
Connor Gramazio (2017)
10.1073/PNAS.1611228113
Structural basis for DNA recognition by STAT6
Jing Li (2016)
10.1186/s12964-018-0253-y
Liprin-α1 modulates cancer cell signaling by transmembrane protein CD82 in adhesive membrane domains linked to cytoskeleton
Henna Pehkonen (2018)
10.1007/s12312-018-0459-3
Implementierung eines IT-gestützten molekularen Tumorboards in der Regelversorgung
Christian Fegeler (2018)
10.1007/978-3-319-99010-1_18
Supervised Classification of Cancers Based on Copy Number Variation
Sanaa Fekry Abed Elsadek (2018)
10.1091/mbc.E17-12-0708
RECK isoforms have opposing effects on cell migration
Ha Neul Lee (2018)
10.1155/2018/9836256
Onco-Multi-OMICS Approach: A New Frontier in Cancer Research
Sajib Chakraborty (2018)
10.1038/s41523-018-0092-4
Cyclin E1 and Rb modulation as common events at time of resistance to palbociclib in hormone receptor-positive breast cancer
C. Guarducci (2018)
10.1002/chem.201804169
Discovery of Small Molecule WWP2 Ubiquitin Ligase Inhibitors.
Jessica E. Watt (2018)
10.1016/j.jcmgh.2018.08.007
The Tumor Suppressor SASH1 Interacts With the Signal Adaptor CRKL to Inhibit Epithelial–Mesenchymal Transition and Metastasis in Colorectal Cancer
Fabian Franke (2019)
10.3390/cancers11010110
Alternating Electric Fields (TTFields) Activate Cav1.2 Channels in Human Glioblastoma Cells
Eric Neuhaus (2019)
10.1038/s41467-019-09307-6
Dissecting heterogeneity in malignant pleural mesothelioma through histo-molecular gradients for clinical applications
Yuna Blum (2019)
10.1016/J.CANCERGEN.2019.04.002
PIP4K2A and PIP4K2C transcript levels are associated with cytogenetic risk and survival outcomes in acute myeloid leukemia.
Keli Carina Miltus Lima (2019)
10.1377/hlthaff.2017.1579
Real-World Evidence In Support Of Precision Medicine: Clinico-Genomic Cancer Data As A Case Study.
Vineeta Agarwala (2018)
10.1038/s41571-018-0028-9
Author Correction: Analysis of DNA methylation in cancer: location revisited
Alexander Koch (2018)
10.1038/s41598-018-23099-7
Effect of CCL5 expression in the recruitment of immune cells in triple negative breast cancer
Jhajaira M Araujo (2018)
10.18632/oncotarget.17544
Osteoclast proton pump regulator Atp6v1c1 enhances breast cancer growth by activating the mTORC1 pathway and bone metastasis by increasing V-ATPase activity
Matthew McConnell (2017)
Tumor and Stem Cell Biology FGFR 1 – WNT – TGF-b Signaling in Prostate Cancer Mouse Models Recapitulates Human Reactive Stroma
Julienne Leigh Carstens (2014)
Umbrella Test the effect of one or more drugs on one or more single mutations in a variety of cancer types Test the impact of different drugs on different mutations in a single type of cancer Basket
Roy S. Herbst (2015)
10.1101/057638
Integrative modeling of tumor DNA methylation identifies a role for metabolism
Mahya Mehrmohamadi (2016)
10.1038/cddis.2014.176
Palmdelphin, a novel target of p53 with Ser46 phosphorylation, controls cell death in response to DNA damage
Nurmaa Dashzeveg (2014)
10.1371/journal.pone.0125482
A Synthetic Lethal Screen Identifies DNA Repair Pathways that Sensitize Cancer Cells to Combined ATR Inhibition and Cisplatin Treatments
Kareem N. Mohni (2015)
See more
Semantic Scholar Logo Some data provided by SemanticScholar